Company news
Allarity Therapeutics, Inc. (NASDAQ:ALLR) news
Allarity Therapeutics, Inc. news releases on 6ix. Latest, May 18, 2022: Correction Notice to Press Release Announcing Financial Results For the Fourth Quarter…
Press releases — page 3
Correction Notice to Press Release Announcing Financial Results For the Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
May 17, 2022
Allarity Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update
May 15, 2022
Allarity Therapeutics Provides Update on Dovitinib Program
March 14, 2022
Allarity Therapeutics Receives Refusal to File Letters from U.S. FDA
February 17, 2022
Allarity Therapeutics and Oncoheroes Biosciences Sign Agreements to Advance Pediatric Cancer Development of Dovitinib and Stenoparib
January 2, 2022